Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sangamo Appoints CEO

Executive Summary

Sangamo Biosciences, a company focused on treating monogenic and infectious diseases using its DNA-binding protein technology, has appointed Alexander 'Sandy' Macrae president and CEO. Macrae will be succeeding current president and CEO Edward Lanphier, who will be retiring from his leadership position but will continue as board member. Macrae previously held roles of increasing responsibility at SmithKline Beecham and GlaxoSmithKline, where his last role was senior vice president, emerging markets research and development.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts